Greenwich Wealth Management’s Annovis Bio ANVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $102K | Buy |
47,000
+900
| +2% | +$1.95K | 0.01% | 243 |
|
|
2025
Q1 | $69K | Buy |
46,100
+14,149
| +44% | +$21.2K | 0.01% | 234 |
|
|
2024
Q4 | $161K | Buy |
31,951
+15,476
| +94% | +$78K | 0.01% | 244 |
|
|
2024
Q3 | $133K | Buy |
16,475
+1,400
| +9% | +$11.3K | 0.01% | 236 |
|
|
2024
Q2 | $87K | Buy |
15,075
+2,500
| +20% | +$14.4K | 0.01% | 234 |
|
|
2024
Q1 | $150K | Buy |
12,575
+2,300
| +22% | +$27.4K | 0.01% | 229 |
|
|
2023
Q4 | $192K | Buy |
+10,275
| New | +$192K | 0.02% | 218 |
|